[go: up one dir, main page]

BRPI0703175B8 - anti-inflammatory and anti-allergic cyclic peptides - Google Patents

anti-inflammatory and anti-allergic cyclic peptides

Info

Publication number
BRPI0703175B8
BRPI0703175B8 BRPI0703175A BRPI0703175A BRPI0703175B8 BR PI0703175 B8 BRPI0703175 B8 BR PI0703175B8 BR PI0703175 A BRPI0703175 A BR PI0703175A BR PI0703175 A BRPI0703175 A BR PI0703175A BR PI0703175 B8 BRPI0703175 B8 BR PI0703175B8
Authority
BR
Brazil
Prior art keywords
allergic
inflammatory
cyclic peptides
chronic
acute
Prior art date
Application number
BRPI0703175A
Other languages
Portuguese (pt)
Inventor
Lima Da Silva Carla
Carvalho Pimenta Daniel
Calheta Vieira Portaro Fernanda
Da Conceição Kátia
Demasi Marilene
Valdyrce Dos Anjos Lopes Ferreira Mônica
Original Assignee
Cristalia Produtos Quim Farmaceuticos Ltda
Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Monica Valdyrce Dos Anjos Lopes Ferreira
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristalia Produtos Quim Farmaceuticos Ltda, Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp, Monica Valdyrce Dos Anjos Lopes Ferreira filed Critical Cristalia Produtos Quim Farmaceuticos Ltda
Priority to BRPI0703175A priority Critical patent/BRPI0703175B8/en
Priority to JP2009521072A priority patent/JP5635771B2/en
Priority to EP07784915A priority patent/EP2046815B1/en
Priority to CN2007800318987A priority patent/CN101511861B/en
Priority to MX2009000800A priority patent/MX2009000800A/en
Priority to HK10101668.7A priority patent/HK1135406B/en
Publication of BRPI0703175A2 publication Critical patent/BRPI0703175A2/en
Publication of BRPI0703175B1 publication Critical patent/BRPI0703175B1/en
Publication of BRPI0703175B8 publication Critical patent/BRPI0703175B8/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

peptídeos cíclicos antiinflamatórios e antialergicos. a presente invenção refere-se a peptídeos cíclicos sintéticos compreendendo uma sequência de 13 l-aminoácidos em sua estrutura primária, que apresentam atividades antiinflamatórias e antialérgicas, úteis para o tratamento de inflamações e/ou alergias, agudas ou crônicas, sendo particularmente úteis para o tratamento da asma alérgica aguda ou crônica. a invenção também descreve uma composição farmacêutica contendo tais peptídeos, uso e método para tratar ou prevenir desordens inflamatórias e/ou alérgicas, agudas e/ou crônicas.anti-inflammatory and anti-allergic cyclic peptides. the present invention relates to synthetic cyclic peptides comprising a sequence of 13 l-amino acids in its primary structure, which have anti-inflammatory and anti-allergic activities, useful for the treatment of inflammation and/or allergies, acute or chronic, being particularly useful for the treatment of acute or chronic allergic asthma. the invention also describes a pharmaceutical composition containing such peptides, use and method for treating or preventing acute and/or chronic inflammatory and/or allergic disorders.

BRPI0703175A 2006-07-21 2007-07-04 anti-inflammatory and anti-allergic cyclic peptides BRPI0703175B8 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BRPI0703175A BRPI0703175B8 (en) 2007-07-04 2007-07-04 anti-inflammatory and anti-allergic cyclic peptides
JP2009521072A JP5635771B2 (en) 2006-07-21 2007-07-19 Anti-inflammatory and anti-allergic cyclic peptides
EP07784915A EP2046815B1 (en) 2006-07-21 2007-07-19 Anti-inflammatory and antiallergic cyclic peptides
CN2007800318987A CN101511861B (en) 2006-07-21 2007-07-19 Anti-inflammatory and anti-allergic cyclic peptides
MX2009000800A MX2009000800A (en) 2006-07-21 2007-07-19 Anti-inflammatory and antiallergic cyclic peptides.
HK10101668.7A HK1135406B (en) 2006-07-21 2007-07-19 Anti-inflammatory and antiallergic cyclic peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0703175A BRPI0703175B8 (en) 2007-07-04 2007-07-04 anti-inflammatory and anti-allergic cyclic peptides

Publications (3)

Publication Number Publication Date
BRPI0703175A2 BRPI0703175A2 (en) 2009-04-14
BRPI0703175B1 BRPI0703175B1 (en) 2019-04-09
BRPI0703175B8 true BRPI0703175B8 (en) 2021-05-25

Family

ID=40612293

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0703175A BRPI0703175B8 (en) 2006-07-21 2007-07-04 anti-inflammatory and anti-allergic cyclic peptides

Country Status (1)

Country Link
BR (1) BRPI0703175B8 (en)

Also Published As

Publication number Publication date
BRPI0703175A2 (en) 2009-04-14
BRPI0703175B1 (en) 2019-04-09

Similar Documents

Publication Publication Date Title
CO6362020A2 (en) MUTANTS FGF21 AND USE OF THE SAME
BR112014033102A2 (en) product for use in the prophylactic or therapeutic treatment of negative emotion or introvert behavior
DE60313597D1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS WITH PROANTHOCYANIDINES, GLYCYRRHETINIC ACID AND TELEMINE TESTS FOR THE TREATMENT OF DERMATITIS
EA202091389A1 (en) PROBIOTIC-BASED COMPOSITION AND ITS APPLICATION
UY38740A (en) MUTANTS OF FGF21 AND USES OF THE SAME
CL2007003054A1 (en) PEPTIDE OF 3 TO 40 AMINO ACIDS CAPABLE OF REGULATING NEURONAL EXOCITOSIS; PROCEDURE FOR OBTAINING SUCH PEPTIDE; COSMETIC AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH PEPTIDE; USE OF SUCH PEPTIDE TO TREAT CONDITIONS THAT REQUIRE REGULAR
BRPI0510428A (en) methadone topical compositions and processes for using them
CR11851A (en) MUTANTS FGF21 AND USES OF THE SAME
BRPI0613358A8 (en) polyunsaturated fat acids for the treatment of dementia and conditions related to pre-dementia
BR112012011332A2 (en) agents directed to gadd45beta
WO2008005303A3 (en) Thiazolopyrimidine modulators of trpv1
BRPI0512864A (en) compositions and methods for treating eye conditions and disorders
CL2009000905A1 (en) Edible composition comprising bifidobacterium longum atcc baa-999; and its use to treat or prevent anxiety and / or anxiety-related disorders.
BR112015009037A2 (en) pharmaceutical composition for use in the treatment of myocardial infarction and use of a hmgb1 fragment peptide
CO6180433A2 (en) LINGO LINK MOLECULES AND PHARMACEUTICAL USE OF THE SAME
UA92636C2 (en) Tetrahydro-pyrimidoazepines as modulators of trpv1
BR112014014410A2 (en) compositions and methods comprising a lipolytic enzyme variant
AR113422A2 (en) RECONSTITUTED SURFACTIVE AGENTS HAVING IMPROVED PROPERTIES
BRPI0817242A2 (en) 1,1,1-Trifluoro-2-hydroxy-3-phenylpropane derivative, process for their manufacture, pharmaceutical compositions containing them, method for treating and / or preventing diseases that are associated with modulation of glucocorticoids and use of such compounds
BR112012020953A2 (en) product, use thereof, method for prevention and / or treatment of corneal fibrosis or corneal opacity and ophthalmic pharmaceutical composition
EP3330252A3 (en) Isoprenyl compounds and methods thereof
BRPI0820967A2 (en) Use of a composition, pharmaceutical composition and method for treating, ameliorating or prophylaxis of the symptoms of an inflammatory disease.
CL2009000309A1 (en) Aromatic fluoroglycoside derivatives, pharmaceutical composition containing these compounds, procedure to prepare it and its use in the treatment of type 1 and type 2 diabetes.
TW200942549A (en) Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
BRPI1010369B8 (en) oil-in-water nanoemulsion cosmetic composition and use of a

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/07/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF